- Home
- FR vs JAZZ Comparison
FR vs JAZZ Comparison
Compare FR & JAZZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FR
- JAZZ
- Stock Information
- Founded
- FR 1993
- JAZZ 2003
- Country
- FR United States
- JAZZ Ireland
- Employees
- FR N/A
- JAZZ N/A
- Industry
- FR Real Estate Investment Trusts
- JAZZ Biotechnology: Pharmaceutical Preparations
- Sector
- FR Real Estate
- JAZZ Health Care
- Exchange
- FR Nasdaq
- JAZZ Nasdaq
- Market Cap
- FR 6.3B
- JAZZ 7.1B
- IPO Year
- FR 1994
- JAZZ 2007
- Fundamental
- Price
- FR $48.89
- JAZZ $117.77
- Analyst Decision
- FR Buy
- JAZZ Strong Buy
- Analyst Count
- FR 11
- JAZZ 12
- Target Price
- FR $55.91
- JAZZ $182.75
- AVG Volume (30 Days)
- FR 866.6K
- JAZZ 805.1K
- Earning Date
- FR 10-15-2025
- JAZZ 08-05-2025
- Dividend Yield
- FR 3.64%
- JAZZ N/A
- EPS Growth
- FR N/A
- JAZZ N/A
- EPS
- FR 2.05
- JAZZ N/A
- Revenue
- FR $700,534,000.00
- JAZZ $4,086,695,000.00
- Revenue This Year
- FR $10.49
- JAZZ $6.10
- Revenue Next Year
- FR $7.34
- JAZZ $5.07
- P/E Ratio
- FR $23.90
- JAZZ N/A
- Revenue Growth
- FR 8.80
- JAZZ 4.52
- 52 Week Low
- FR $40.31
- JAZZ $95.49
- 52 Week High
- FR $58.17
- JAZZ $148.06
- Technical
- Relative Strength Index (RSI)
- FR 50.26
- JAZZ 58.29
- Support Level
- FR $48.03
- JAZZ $105.00
- Resistance Level
- FR $49.20
- JAZZ $117.21
- Average True Range (ATR)
- FR 0.87
- JAZZ 3.36
- MACD
- FR 0.01
- JAZZ 0.20
- Stochastic Oscillator
- FR 54.27
- JAZZ 96.96
About FR First Industrial Realty Trust Inc.
First Industrial Realty Trust Inc is a real estate investment trust that owns, manages, acquires, sells, develops, and redevelops industrial real estate. Through its fully integrated operating and investing platform, the company provides facilities and customer service to multinational corporations and regional firms that are essential for their supply chains. The company serves a diverse tenant base across various sectors, including e-commerce, logistics, transportation, manufacturing, retail, consumer services, food and beverage, building materials, wholesale goods, health services, and government.
About JAZZ Jazz Pharmaceuticals plc (Ireland)
Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.